Stephane Clement Krief

Title: The Innovations of Stephane Clement Krief

Introduction

Stephane Clement Krief is a notable inventor based in Montgermont, France. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compounds and diagnostic methods. With a total of 2 patents, his work has the potential to impact various medical conditions.

Latest Patents

Krief's latest patents include innovative compounds related to ANT5 polypeptides and polynucleotides. These patents disclose methods for producing such polypeptides through recombinant techniques. Additionally, they outline therapeutic applications and diagnostic assays for utilizing ANT5 polypeptides and polynucleotides. Another significant patent involves Putative Adrenomedullin Receptor polypeptides and polynucleotides. This patent details methods for producing these polypeptides and their applications in treating infections, pain, cancers, diabetes, and various neurological disorders, among others.

Career Highlights

Throughout his career, Krief has worked with prominent organizations, including SmithKline Beecham Laboratories Pharmaceutiques. His experience in these companies has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Krief has collaborated with notable individuals in his field, including Michel Louis Souchet and George Henry Poste. These collaborations have likely enriched his research and development efforts.

Conclusion

Stephane Clement Krief's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies and diagnostics.